Drugs that contain Fenofibrate

1. Drug name - ANTARA (MICRONIZED)

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8026281 LUPIN Treating metabolic syndrome with fenofibrate Apr, 2025

(2 years from now)

US9314447 LUPIN Reduced dose pharmaceutical compositions of fenofibrate May, 2033

(10 years from now)

Treatment: Treating severe hypertriglyceridemia; treating primary hypercholesterolemia and mixed dyslipidemia; Treating primary hypercholesterolemia and mixed dyslipidemia; treating severe hypertriglyceridemia

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
30MG CAPSULE;ORAL Prescription
43MG CAPSULE;ORAL Prescription
87MG CAPSULE;ORAL Discontinued
90MG CAPSULE;ORAL Prescription
130MG CAPSULE;ORAL Prescription

2. Drug name - FENOGLIDE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9173847 SALIX Tablet comprising a fibrate Oct, 2024

(2 years from now)

US8124125 SALIX Solid dosage form comprising a fibrate Oct, 2024

(2 years from now)

US8481078 SALIX Solid dosage form comprising a fibrate Oct, 2024

(2 years from now)

US7658944 SALIX Solid dosage form comprising a fibrate Dec, 2024

(2 years from now)

Treatment: For reducing total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides, and treating hypertriglyceridemia; Use of fenofibrate for reducing elevated total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
40MG TABLET;ORAL Prescription
120MG TABLET;ORAL Prescription

3. Drug name - TRICOR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7276249 ABBVIE Nanoparticulate fibrate formulations Feb, 2023

(4 months from now)

US7320802 ABBVIE Methods of treatment using nanoparticulate fenofibrate compositions Feb, 2023

(4 months from now)

Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v)

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
48MG TABLET;ORAL Prescription
145MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.